Back to search
FDAFDA · Food and drugs·Recall number D-0174-2025

phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25

Published January 8, 2025 · Recall initiated: December 19, 2024

Summary

FDA records drug Class II recall D-0174-2025, published January 8, 2025 and initiated December 19, 2024. Recalling firm: Hikma Injectables USA Inc; Status: Terminated; Lot: Lot number: 243120003D, Use by Date: 03/11/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hikma Injectables USA Inc
Distributor
Nationwide in the USA
Lot
Lot number: 243120003D, Use by Date: 03/11/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25 recalled?

Yes. FDA published recall D-0174-2025 on January 8, 2025. Reported hazard: Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.

What should I do if I have this product?

Voluntary: Firm initiated · Letter